Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1
Abstract E74-like ETS transcription factor 5 (ELF5) is involved in a wide spectrum of biological processes, e.g., mammogenesis and tumor progression. We have identified a list of p300-interacting proteins in human breast cancer cells. Among these, ELF5 was found to interact with p300 via acetylation...
Guardado en:
Autores principales: | Xiahui Li, Shujing Li, Bowen Li, Yanan Li, Sattout Aman, Kangkai Xia, Yuxi Yang, Bashir Ahmad, Huijian Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/763b9e5df05043e0a6a0ddf5e84af082 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9
por: Sattout Aman, et al.
Publicado: (2021) -
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
por: Maria Kalyuga, et al.
Publicado: (2012) -
Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression
por: Yang Chen, et al.
Publicado: (2017) -
Cell Cycle Regulation by Alternative Polyadenylation of CCND1
por: Qiong Wang, et al.
Publicado: (2018) -
Acetylation-mediated suppression of transcription-independent memory: bidirectional modulation of memory by acetylation.
por: Katja Merschbaecher, et al.
Publicado: (2012)